Literature DB >> 8842752

Efficient production of IgG human monoclonal antibodies by lymphocytes stimulated by lipopolysaccharide, pokeweed mitogen, and interleukin 4.

K Yoshinari1, K Arai, H Kimura, K Matsumoto, Y Yamaguchi.   

Abstract

Extensive screening of the mitogens lipopolysaccharide (LPS), pokeweed mitogen (PWM), and Staphylococcus aureus Cowan I (SAC I), alone and in combination and with and without interleukin (IL) was performed for in vitro activation of regional lymph node lymphocytes from lung cancer patients for the production of human IgG, IgM, and IgA. As assessed by electrofusion of the lymphocytes following their exposure to these agents with mouse myeloma cells and incubation of the fused hybridoma, a remarkable stimulatory effect was shown by LPS and particularly by LPS plus IL-4, which was substantially greater than that of either SAC I or PWM with or without various IL. Optimization studies indicated that the addition of PWM to LPS and IL-4 in the culture medium further stimulated the human antibody (Ab) production, and that the optimal formulation for stimulation of human IgG production was a culture medium containing 20 micrograms/ml of LPS, 1/500 of PWM, and 100 u/ml of IL-4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842752     DOI: 10.1007/bf02722964

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  28 in total

1.  Efficient hybridization of mouse-human cell lines by means of hypo-osmolar electrofusion.

Authors:  U Zimmermann; P Gessner; R Schnettler; S Perkins; S K Foung
Journal:  J Immunol Methods       Date:  1990-11-06       Impact factor: 2.303

Review 2.  CD14: cell surface receptor and differentiation marker.

Authors:  H W Ziegler-Heitbrock; R J Ulevitch
Journal:  Immunol Today       Date:  1993-03

3.  IL-4 induces the specific rearrangement of gamma 1 genes on the expressed and unexpressed chromosomes of lipopolysaccharide-activated normal murine B cells.

Authors:  M R Kepron; Y W Chen; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

4.  In vitro production of antibody in cultures of human peripheral blood lymphocytes.

Authors:  D T Umetsu; R S Geha
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 5.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Human B cells express membrane-bound and soluble forms of the CD14 myeloid antigen.

Authors:  M O Labeta; R Landmann; J P Obrecht; R Obrist
Journal:  Mol Immunol       Date:  1991 Jan-Feb       Impact factor: 4.407

7.  Antigen-specific human antibodies from mice comprising four distinct genetic modifications.

Authors:  N Lonberg; L D Taylor; F A Harding; M Trounstine; K M Higgins; S R Schramm; C C Kuo; R Mashayekh; K Wymore; J G McCabe
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

8.  Interleukin 1 can act as a B-cell growth and differentiation factor.

Authors:  B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  First establishment of a human monoclonal antibody directed to sulfated glycosphingolipids SM4s-Gal and SM4g, from a patient with lung cancer.

Authors:  M Miyake; T Taki; R Kannagi; S Hitomi
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

10.  Differential regulation of IgG1 and IgE synthesis by interleukin 4.

Authors:  C M Snapper; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  2 in total

1.  Relationship between antibody productivity by activated human lymph node lymphocytes from lung cancer patients and lymphocyte subsets.

Authors:  K Yoshinari; K Arai; K Matsumoto; H Kimura
Journal:  Cytotechnology       Date:  1999-05       Impact factor: 2.058

Review 2.  Exploring the native human antibody repertoire to create antiviral therapeutics.

Authors:  S K Dessain; S P Adekar; J D Berry
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.